Posttraumatic stress disorder and depression of survivors 12 months after the outbreak of Middle East respiratory syndrome in South Korea - Park HY, Park WB, Lee SH, Kim JL, Lee JJ, Lee H, Shin HS.
BACKGROUND: The 2015 outbreak of Middle East Respiratory Syndrome (MERS) in the Republic of Korea is a recent and representative occurrence of nationwide outbreaks of Emerging Infectious Diseases (EIDs). In addition to physical symptoms, posttraumatic stre... (Source: SafetyLit)
Source: SafetyLit - May 19, 2020 Category: International Medicine & Public Health Tags: Economics of Injury and Safety, PTSD, Injury Outcomes Source Type: news
Delirium and agitation may follow Covid-19 infection, study says
A study compares what we know about the long-term mental impact of past coronaviruses like MERS and SARS to today's novel coronavirus. (Source: CNN.com - Health)
Source: CNN.com - Health - May 19, 2020 Category: Consumer Health News Source Type: news
The Lancet Psychiatry: Study finds few immediate mental health effects of COVID-19, but longer-term impact must be considered
(The Lancet) Most people admitted to hospital with severe COVID-19 should recover without experiencing mental illness if infection with SARS-CoV-2 follows a similar course to the coronavirus epidemics of severe acute respiratory syndrome (SARS) in 2002 and Middle East respiratory syndrome (MERS) in 2012, according to the first systematic review and meta-analysis looking at the psychiatric consequences of coronavirus infections in over 3,550 patients hospitalised with SARS, MERS, and COVID-19, published in The Lancet Psychiatry journal. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - May 18, 2020 Category: Infectious Diseases Source Type: news
Covid-19 test results could mislead public | Letters
Dr Michael Browning is concerned by the limitations of the Roche antibody test, whileDennis Sherwoodis worried about the reliability of self-administered swabsPublic Health England ’s report on its validation of the Roche Covid-19 antibody test (which the government is promoting for widespread use) reveals a number of limitations that were not mentioned in the public briefings (Public Health England approves Roche test for coronavirus antibodies, 13 May). The test showed inadequate levels of sensitivity for detecting antibodies to Covid-19 until 40 days after the onset of symptoms, so will only be useful from six weeks a...
Source: Guardian Unlimited Science - May 17, 2020 Category: Science Authors: Letters Tags: Coronavirus outbreak Infectious diseases Medical research Science Health policy Imperial College London Biology Source Type: news
Coronavirus Treatment: Remdesivir Arrives At Some Mass. Hospitals In Limited Supply
BOSTON (CBS) – In the race to find a treatment for COVID-19, a drug that’s showing potential has reached some Massachusetts hospitals. It’s called remdesivir and it’s made by the California-based pharmaceutical company Gilead Sciences Inc. The FDA approved the drug for emergency use on May 1st.
“Remdesivir is a broad spectrum antiviral agent, it targets viruses specifically,” said Vice Chair of Emergency Medicine at Massachusetts General, Dr. Ali Raja. “It was initially developed for viruses like SARS or MERS but it never got approved for those.”
Last week, the federal gove...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - May 11, 2020 Category: Consumer Health News Authors: Health – CBS Boston Tags: Boston News Health Syndicated Local Anaridis Rodriguez Coronavirus remdesivir Source Type: news
Stronger and Safer Than Any Vaccine …
The coronavirus exposed the fatal flaw of our mainstream health system: the misguided dependence on the U.S. government and Big Pharma to save the day.
Dozens of companies are now in a race to develop a coronavirus vaccine and treatment drugs — with billions of dollars in profits going to the winner.
I have news for you: The vaccine won’t stop this virus.
You can’t eradicate a virus like this with an external weapon like a vaccine, any more than you can eradicate seasonal flu or the common cold.
But you can make sure you never get the coronavirus in the first place — or any other disease-causing infecti...
Source: Al Sears, MD Natural Remedies - May 8, 2020 Category: Complementary Medicine Authors: Dr.A.Sears Tags: Health Source Type: news
KIST-CUK research team develops vaccine platform applicable to various viruses
(National Research Council of Science& Technology) MERS, which struck South Korea in a 2015 outbreak, was caused by a coronavirus--the same family of viruses that is responsible for COVID-19. Recently, a Korean research team announced that it had developed a new vaccine platform using RNA-based adjuvants for the MERS coronavirus. The research team successfully conducted an experiment on nonhuman primates. It is expected that the new vaccine platform will soon be applicable to the development of a COVID-19 vaccine, an urgent global health priority. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 8, 2020 Category: International Medicine & Public Health Source Type: news
Pediatric coronavirus disease (COVID-19) x-ray, CT in review of new lung disorders
(American Roentgen Ray Society) Although the clinical symptoms of SARS, H1N1, MERS, EVALI, and COVID-19 may be nonspecific, some characteristic imaging findings are emerging, says the American Journal of Roentgenology (AJR). Careful evaluation of the distribution, lung zone preference, and symmetry of the abnormalities with an eye for a few unique differentiating imaging features can allow radiologists to offer a narrower differential diagnosis in pediatric patients, leading to optimal patient care. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - May 8, 2020 Category: Infectious Diseases Source Type: news
Hoping Llamas Will Become Coronavirus Heroes
Antibodies from Winter, a 4-year-old llama with great eyelashes, have neutralized coronavirus and other infections in lab experiments. (Source: NYT Health)
Source: NYT Health - May 6, 2020 Category: Consumer Health News Authors: Jillian Kramer Tags: Llamas Coronavirus (2019-nCoV) Antibodies Research SARS (Severe Acute Respiratory Syndrome) MERS (Middle East Respiratory Syndrome) Cell (Journal) your-feed-science McLellan, Jason (Researcher) Saelens, Xavier Wrapp, Daniel (Researcher Source Type: news
The Baltimore Bioterrorism Expert Who Inspired South Korea ’s COVID-19 Response
On Oct. 2, 2001, a 62-year-old photojournalist named Bob Stevens became the first victim of a coordinated series of anthrax attacks to be admitted to hospital. Stevens inhaled the deadly pathogen after opening one of several letters laced with anthrax spores which were mailed to the offices of prominent senators and media outlets across the U.S. Over the next seven weeks, he and four others would die as a result of their exposure.
For a shell-shocked nation still reeling from the single deadliest terrorist attack in human history on September 11, it was a disturbing realization that there was a new wave of challenges to Am...
Source: TIME: Health - May 6, 2020 Category: Consumer Health News Authors: David Cox Tags: Uncategorized COVID-19 Source Type: news
Bat 'super immunity' may explain how bats carry coronaviruses -- USask study
(University of Saskatchewan) A University of Saskatchewan (USask) research team has uncovered how bats can carry the Middle East respiratory syndrome (MERS) coronavirus without getting sick -- research that could shed light on how coronaviruses make the jump to humans and other animals. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 6, 2020 Category: International Medicine & Public Health Source Type: news
Middle East respiratory syndrome coronavirus (MERS-CoV) – Saudi Arabia
From 1 through 31 March 2020, the National IHR Focal Point of Saudi Arabia reported 15 additional cases of MERS-CoV infection, including five associated deaths. The cases were reported from Riyadh (7 cases), Makkah (4 cases), Najran (3 cases), and Al Qassim (1 case) regions. The link below provides details of the 15 reported cases. (Source: WHO Disease Outbreaks)
Source: WHO Disease Outbreaks - May 5, 2020 Category: Infectious Diseases Tags: news Source Type: news
This is what you should be demanding from your government to contain the virus | Devi Sridhar
Four months in, we know what works against coronavirus. These are eight important lessons from east AsiaDevi Sridhar is chair of global public health at the University of EdinburghCoronavirus – latest updatesKnowing how to control the spread of coronavirus is not rocket science. But actually doing it has proved elusive and difficult for many governments across the world. When China first alerted the World Health Organization about a novel coronavirus on31 December, the countdown began for countries to each prepare. Some, such as South Korea, Taiwan and Hong Kong, were scarred by their recent experiences with two other de...
Source: Guardian Unlimited Science - May 4, 2020 Category: Science Authors: Devi Sridhar Tags: Coronavirus outbreak Infectious diseases Medical research Science World news Politics UK news Source Type: news
COMMENTARY: COVID-19: Don't Forget About Plasmapheresis
The strategy to filter out virions from infected plasma has been tested with the Middle East respiratory syndrome coronavirus. Why not consider it for SARS-CoV2, asks nephrologist Tejas Desai. (Source: WebMD Health)
Source: WebMD Health - April 29, 2020 Category: Consumer Health News Source Type: news
Remdesivir Shows Promising Results as a Coronavirus Treatment, According to Drug Manufacturer Gilead
Gilead, a California-based biopharmaceutical company, released two encouraging reports about remdesivir, an experimental drug that is being tested as a COVID-19 treatment.
In one statement, the company said that a large study of remdesivir “met its primary endpoint”: meaning, in this case, that the researchers have concluded that hospitalized patients taking the drug appear to improve faster than patients given a placebo. The study is run by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. National Institutes of Health and involves severe patients at multiple centers across th...
Source: TIME: Health - April 29, 2020 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized COVID-19 Source Type: news
